Is GDR or ABDX more profitable?

Abingdon Health has a net margin of -33.88% compared to genedrive's net margin of -500.75%. Abingdon Health's return on equity of -55.91% beat genedrive's return on equity. Company Net Margins Return on Equity Return on Assets genedrive -500.75% -1,044.57% -74.09% Abingdon Health -33.88% -55.91% -17.93%

Is GDR or YGEN more profitable?

Yourgene Health has a net margin of -27.55% compared to genedrive's net margin of -500.75%. Yourgene Health's return on equity of -27.06% beat genedrive's return on equity. Company Net Margins Return on Equity Return on Assets genedrive -500.75% -1,044.57% -74.09% Yourgene Health -27.55% -27.06% -6.71%

Which has stronger valuation & earnings, GDR or AGL?

genedrive has higher earnings, but lower revenue than ANGLE. genedrive is trading at a lower price-to-earnings ratio than ANGLE, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio genedrive £929K 23.57 -£21.22M -£0.79 N/A ANGLE £2.62M 2.89 -£21.76M -£4.80 N/A

Is GDR or AGL more profitable?

genedrive has a net margin of -500.75% compared to ANGLE's net margin of -1,444.04%. ANGLE's return on equity of -191.36% beat genedrive's return on equity. Company Net Margins Return on Equity Return on Assets genedrive -500.75% -1,044.57% -74.09% ANGLE -1,444.04% -191.36% -29.89%

Does the media favor GDR or AGL?

In the previous week, genedrive and genedrive both had 1 articles in the media. genedrive's average media sentiment score of 0.68 beat ANGLE's score of 0.00 indicating that genedrive is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment genedrive 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive ANGLE 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has better valuation and earnings, GENI or GDR?

GENinCode has higher revenue and earnings than genedrive. genedrive is trading at a lower price-to-earnings ratio than GENinCode, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio GENinCode £3.08M 2.09 -£6.10M -£2.08 N/A genedrive £929K 23.57 -£21.22M -£0.79 N/A

Is GENI or GDR more profitable?

GENinCode has a net margin of -185.47% compared to genedrive's net margin of -500.75%. GENinCode's return on equity of -409.40% beat genedrive's return on equity. Company Net Margins Return on Equity Return on Assets GENinCode -185.47% -409.40% -63.99% genedrive -500.75% -1,044.57% -74.09%

Is PRM or GDR more profitable?

Proteome Sciences has a net margin of -81.50% compared to genedrive's net margin of -500.75%. Proteome Sciences' return on equity of 33.80% beat genedrive's return on equity. Company Net Margins Return on Equity Return on Assets Proteome Sciences -81.50% 33.80% -19.25% genedrive -500.75% -1,044.57% -74.09%

Does the media favor PRM or GDR?

In the previous week, Proteome Sciences and Proteome Sciences both had 1 articles in the media. genedrive's average media sentiment score of 0.68 beat Proteome Sciences' score of 0.00 indicating that genedrive is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Proteome Sciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral genedrive 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

genedrive (GDR) Competitors

GBX 1.36 +0.06 (+4.92%)

As of 12:34 PM Eastern

Compare

GDR vs. ABDX, YGEN, AGL, GENI, and PRM

Should you buy genedrive stock or one of its competitors? genedrive's main competitors and comparable companies include Abingdon Health (ABDX), Yourgene Health (YGEN), ANGLE (AGL), GENinCode (GENI), and Proteome Sciences (PRM). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "life sciences tools & services" industry.

How does genedrive compare to Abingdon Health?

genedrive (LON:GDR) and Abingdon Health (LON:ABDX) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, profitability, risk, institutional ownership, media sentiment, analyst recommendations and dividends.

Abingdon Health has higher revenue and earnings than genedrive. Abingdon Health is trading at a lower price-to-earnings ratio than genedrive, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
genedrive	£929K	23.57	-£21.22M	-£0.79	N/A
Abingdon Health	£9.57M	2.76	-£796.37K	-£0.81	N/A

0.1% of genedrive shares are held by institutional investors. Comparatively, 3.7% of Abingdon Health shares are held by institutional investors. 29.0% of genedrive shares are held by company insiders. Comparatively, 8.0% of Abingdon Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Abingdon Health has a net margin of -33.88% compared to genedrive's net margin of -500.75%. Abingdon Health's return on equity of -55.91% beat genedrive's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
genedrive	-500.75%	-1,044.57%	-74.09%
Abingdon Health	-33.88%	-55.91%	-17.93%

genedrive has a beta of 0.989, suggesting that its share price is 1% less volatile than the broader market. Comparatively, Abingdon Health has a beta of 0.132, suggesting that its share price is 87% less volatile than the broader market.

In the previous week, genedrive had 1 more articles in the media than Abingdon Health. MarketBeat recorded 1 mentions for genedrive and 0 mentions for Abingdon Health. genedrive's average media sentiment score of 0.68 beat Abingdon Health's score of 0.00 indicating that genedrive is being referred to more favorably in the media.

Company	Overall Sentiment
genedrive	Positive
Abingdon Health	Neutral

Summary

genedrive beats Abingdon Health on 7 of the 13 factors compared between the two stocks.

How does genedrive compare to Yourgene Health?

genedrive (LON:GDR) and Yourgene Health (LON:YGEN) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, analyst recommendations, media sentiment, risk, dividends, profitability and institutional ownership.

0.1% of genedrive shares are held by institutional investors. Comparatively, 23.3% of Yourgene Health shares are held by institutional investors. 29.0% of genedrive shares are held by company insiders. Comparatively, 64.4% of Yourgene Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Yourgene Health has higher revenue and earnings than genedrive. genedrive is trading at a lower price-to-earnings ratio than Yourgene Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
genedrive	£929K	23.57	-£21.22M	-£0.79	N/A
Yourgene Health	£29.67M	0.00	-£8.17M	-£0.01	N/A

genedrive has a beta of 0.989, meaning that its share price is 1% less volatile than the broader market. Comparatively, Yourgene Health has a beta of 0.86, meaning that its share price is 14% less volatile than the broader market.

Yourgene Health has a net margin of -27.55% compared to genedrive's net margin of -500.75%. Yourgene Health's return on equity of -27.06% beat genedrive's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
genedrive	-500.75%	-1,044.57%	-74.09%
Yourgene Health	-27.55%	-27.06%	-6.71%

In the previous week, genedrive had 1 more articles in the media than Yourgene Health. MarketBeat recorded 1 mentions for genedrive and 0 mentions for Yourgene Health. genedrive's average media sentiment score of 0.68 beat Yourgene Health's score of 0.00 indicating that genedrive is being referred to more favorably in the media.

Company	Overall Sentiment
genedrive	Positive
Yourgene Health	Neutral

Summary

Yourgene Health beats genedrive on 8 of the 12 factors compared between the two stocks.

How does genedrive compare to ANGLE?

genedrive (LON:GDR) and ANGLE (LON:AGL) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, valuation, profitability, media sentiment and institutional ownership.

In the previous week, genedrive and genedrive both had 1 articles in the media. genedrive's average media sentiment score of 0.68 beat ANGLE's score of 0.00 indicating that genedrive is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
genedrive	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
ANGLE	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

genedrive has higher earnings, but lower revenue than ANGLE. genedrive is trading at a lower price-to-earnings ratio than ANGLE, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
genedrive	£929K	23.57	-£21.22M	-£0.79	N/A
ANGLE	£2.62M	2.89	-£21.76M	-£4.80	N/A

0.1% of genedrive shares are owned by institutional investors. Comparatively, 17.5% of ANGLE shares are owned by institutional investors. 29.0% of genedrive shares are owned by company insiders. Comparatively, 2.7% of ANGLE shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

genedrive has a beta of 0.989, suggesting that its stock price is 1% less volatile than the broader market. Comparatively, ANGLE has a beta of 0.22, suggesting that its stock price is 78% less volatile than the broader market.

genedrive has a net margin of -500.75% compared to ANGLE's net margin of -1,444.04%. ANGLE's return on equity of -191.36% beat genedrive's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
genedrive	-500.75%	-1,044.57%	-74.09%
ANGLE	-1,444.04%	-191.36%	-29.89%

Summary

genedrive beats ANGLE on 7 of the 12 factors compared between the two stocks.

How does genedrive compare to GENinCode?

GENinCode (LON:GENI) and genedrive (LON:GDR) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, valuation, dividends, institutional ownership, profitability, analyst recommendations, earnings and risk.

GENinCode has higher revenue and earnings than genedrive. genedrive is trading at a lower price-to-earnings ratio than GENinCode, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GENinCode	£3.08M	2.09	-£6.10M	-£2.08	N/A
genedrive	£929K	23.57	-£21.22M	-£0.79	N/A

GENinCode has a net margin of -185.47% compared to genedrive's net margin of -500.75%. GENinCode's return on equity of -409.40% beat genedrive's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GENinCode	-185.47%	-409.40%	-63.99%
genedrive	-500.75%	-1,044.57%	-74.09%

In the previous week, genedrive had 1 more articles in the media than GENinCode. MarketBeat recorded 1 mentions for genedrive and 0 mentions for GENinCode. genedrive's average media sentiment score of 0.68 beat GENinCode's score of 0.00 indicating that genedrive is being referred to more favorably in the news media.

Company	Overall Sentiment
GENinCode	Neutral
genedrive	Positive

GENinCode has a beta of 0.557, meaning that its stock price is 44% less volatile than the broader market. Comparatively, genedrive has a beta of 0.989, meaning that its stock price is 1% less volatile than the broader market.

11.4% of GENinCode shares are held by institutional investors. Comparatively, 0.1% of genedrive shares are held by institutional investors. 8.4% of GENinCode shares are held by company insiders. Comparatively, 29.0% of genedrive shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

GENinCode beats genedrive on 7 of the 13 factors compared between the two stocks.

How does genedrive compare to Proteome Sciences?

Proteome Sciences (LON:PRM) and genedrive (LON:GDR) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership and profitability.

Proteome Sciences has a beta of 0.148, meaning that its share price is 85% less volatile than the broader market. Comparatively, genedrive has a beta of 0.989, meaning that its share price is 1% less volatile than the broader market.

Proteome Sciences has higher revenue and earnings than genedrive. Proteome Sciences is trading at a lower price-to-earnings ratio than genedrive, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Proteome Sciences	£3.76M	1.73	-£4.08M	-£1.04	N/A
genedrive	£929K	23.57	-£21.22M	-£0.79	N/A

0.0% of Proteome Sciences shares are held by institutional investors. Comparatively, 0.1% of genedrive shares are held by institutional investors. 36.7% of Proteome Sciences shares are held by company insiders. Comparatively, 29.0% of genedrive shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Proteome Sciences has a net margin of -81.50% compared to genedrive's net margin of -500.75%. Proteome Sciences' return on equity of 33.80% beat genedrive's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Proteome Sciences	-81.50%	33.80%	-19.25%
genedrive	-500.75%	-1,044.57%	-74.09%

In the previous week, Proteome Sciences and Proteome Sciences both had 1 articles in the media. genedrive's average media sentiment score of 0.68 beat Proteome Sciences' score of 0.00 indicating that genedrive is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Proteome Sciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
genedrive	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Proteome Sciences and genedrive tied by winning 6 of the 12 factors compared between the two stocks.

Get genedrive News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GDR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

GDR vs. The Competition

Export

Metric	genedrive	Life Sciences Tools & Services Industry	Healthcare Sector	LON Exchange
Market Cap	£21.90M	£10.21B	£7.40B	£2.92B
Dividend Yield	1.57%	1.46%	2.53%	6.17%
P/E Ratio	-1.72	63.20	272.19	367.32
Price / Sales	23.57	111.26	631.76	83,741.35
Price / Cash	2.00	27.09	79.89	27.89
Price / Book	0.48	37.51	13.14	7.02
Net Income	-£21.22M	£56.67B	£3.47B	£5.89B
7 Day Performance	9.82%	2.12%	1.38%	0.89%
1 Month Performance	33.73%	10.71%	8.62%	3.27%
1 Year Performance	70.93%	25.70%	25.90%	22.28%

genedrive Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
GDR genedrive	N/A	GBX 1.36 +4.9%	N/A	+59.1%	£21.90M	£929K	N/A	43	Positive News Gap Up
ABDX Abingdon Health	N/A	GBX 10.04 -4.4%	N/A	+86.5%	£26.36M	£9.57M	N/A	84	Gap Up
YGEN Yourgene Health	N/A	N/A	N/A	N/A	£16.43M	£29.67M	N/A	253
AGL ANGLE	N/A	GBX 2.35 -11.3%	N/A	-63.8%	£7.58M	£2.62M	N/A	650	Gap Up
GENI GENinCode	N/A	GBX 0.89 -1.2%	N/A	-36.8%	£6.70M	£3.08M	N/A	2,300

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:GDR) was last updated on 8/26/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

genedrive (GDR) Competitors

GDR vs. ABDX, YGEN, AGL, GENI, and PRM

How does genedrive compare to Abingdon Health?

Summary

How does genedrive compare to Yourgene Health?

Summary

How does genedrive compare to ANGLE?

Summary

How does genedrive compare to GENinCode?

Summary

How does genedrive compare to Proteome Sciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GDR vs. The Competition

genedrive Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

genedrive (GDR) Competitors

GDR vs. ABDX, YGEN, AGL, GENI, and PRM

How does genedrive compare to Abingdon Health?

Which has stronger valuation and earnings, GDR or ABDX?

Do insiders & institutionals hold more shares of GDR or ABDX?

Is GDR or ABDX more profitable?

Which has more risk and volatility, GDR or ABDX?

Does the media prefer GDR or ABDX?

Summary

How does genedrive compare to Yourgene Health?

Do insiders and institutionals believe in GDR or YGEN?

Which has better valuation & earnings, GDR or YGEN?

Which has more volatility & risk, GDR or YGEN?

Is GDR or YGEN more profitable?

Does the media refer more to GDR or YGEN?

Summary

How does genedrive compare to ANGLE?

Does the media favor GDR or AGL?

Which has stronger valuation & earnings, GDR or AGL?

Do institutionals and insiders hold more shares of GDR or AGL?

Which has more risk & volatility, GDR or AGL?

Is GDR or AGL more profitable?

Summary

How does genedrive compare to GENinCode?

Which has better valuation and earnings, GENI or GDR?

Is GENI or GDR more profitable?

Does the media prefer GENI or GDR?

Which has more volatility & risk, GENI or GDR?

Do institutionals and insiders have more ownership in GENI or GDR?

Summary

How does genedrive compare to Proteome Sciences?

Which has more risk & volatility, PRM or GDR?

Which has stronger valuation and earnings, PRM or GDR?

Do insiders & institutionals have more ownership in PRM or GDR?

Is PRM or GDR more profitable?

Does the media favor PRM or GDR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GDR vs. The Competition

genedrive Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools